Nemaura Medical Stock Net Asset
| NMRDDelisted Stock | USD 0.93 0.01 1.06% |
Nemaura Medical fundamentals help investors to digest information that contributes to Nemaura Medical's financial success or failures. It also enables traders to predict the movement of Nemaura Pink Sheet. The fundamental analysis module provides a way to measure Nemaura Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nemaura Medical pink sheet.
Nemaura |
Nemaura Medical Company Net Asset Analysis
Nemaura Medical's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Nemaura Medical Net Asset | 14.56 M |
Most of Nemaura Medical's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nemaura Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, Nemaura Medical has a Net Asset of 14.56 M. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Nemaura Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nemaura Medical's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nemaura Medical could also be used in its relative valuation, which is a method of valuing Nemaura Medical by comparing valuation metrics of similar companies.Nemaura Medical is currently under evaluation in net asset category among its peers.
Nemaura Fundamentals
| Return On Equity | -7.24 | ||||
| Return On Asset | -0.49 | ||||
| Current Valuation | 22.58 M | ||||
| Shares Outstanding | 28.9 M | ||||
| Shares Owned By Insiders | 48.30 % | ||||
| Shares Owned By Institutions | 7.70 % | ||||
| Number Of Shares Shorted | 52.57 K | ||||
| Price To Earning | (707.14) X | ||||
| Price To Book | 122.56 X | ||||
| Price To Sales | 804.62 X | ||||
| Revenue | 77.04 K | ||||
| Gross Profit | (1.48 M) | ||||
| EBITDA | (8.17 M) | ||||
| Net Income | (14.14 M) | ||||
| Cash And Equivalents | 14.75 M | ||||
| Cash Per Share | 0.61 X | ||||
| Total Debt | 20.03 M | ||||
| Current Ratio | 0.99 X | ||||
| Book Value Per Share | (0.55) X | ||||
| Cash Flow From Operations | (8.45 M) | ||||
| Short Ratio | 0.30 X | ||||
| Earnings Per Share | (0.39) X | ||||
| Target Price | 3.5 | ||||
| Number Of Employees | 36 | ||||
| Beta | 0.046 | ||||
| Market Capitalization | 2.43 M | ||||
| Total Asset | 14.56 M | ||||
| Retained Earnings | (51.88 M) | ||||
| Working Capital | (8.73 M) | ||||
| Current Asset | 9.55 M | ||||
| Current Liabilities | 658.01 K | ||||
| Z Score | -7.48 | ||||
| Net Asset | 14.56 M |
About Nemaura Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nemaura Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nemaura Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nemaura Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Nemaura Pink Sheet
If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |